4//SEC Filing
Boral Anthony L. 4
Accession 0001179110-20-009901
CIK 0001597264other
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 4:22 PM ET
Size
15.7 KB
Accession
0001179110-20-009901
Insider Transaction Report
Form 4
Boral Anthony L.
Sr. VP, Clinical Development
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-09-17−9,879→ 24,347 totalExercise: $15.01Exp: 2026-02-03→ Common Stock (9,879 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-09-17−3,030→ 0 totalExercise: $8.80Exp: 2025-02-10→ Common Stock (3,030 underlying) - Exercise/Conversion
Common Stock
2020-09-17$8.80/sh+3,030$26,664→ 31,873 total - Exercise/Conversion
Common Stock
2020-09-17$15.01/sh+9,879$148,284→ 28,843 total - Sale
Common Stock
2020-09-17$80.00/sh−23,136$1,850,880→ 18,964 total - Exercise/Conversion
Common Stock
2020-09-17$8.80/sh+10,227$89,998→ 42,100 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-09-17−10,227→ 0 totalExercise: $8.80Exp: 2025-02-10→ Common Stock (10,227 underlying)
Footnotes (4)
- [F1]Effected pursuant to a trading plan adopted on March 17, 2020 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $80.05 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]This option was granted on February 3, 2016. This option is fully vested as of the date hereof.
- [F4]This option was granted on February 10, 2015. This option is fully vested as of the date hereof.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001638468
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 4:22 PM ET
- Size
- 15.7 KB